Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Xuan Lin

T-Lymphokine-Activated Killer Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Glioma

Oncotarget

Oncology

2017

English

Unique Stabilizing Mechanism Provided by Biocompatible Choline-Based Ionic Liquids for Inhibiting Dissociation of Inactivated Foot-And-Mouth Disease Virus Particles

English

Related publications

T‐lymphokine‐activated Killer Cell‐originated Protein Kinase (TOPK)‐positive Colorectal Tumor Growth Is Suppressed by Acetylshikonin

British Journal of Pharmacology

Pharmacology

2020

English

Cloning and Expression of a Novel MAPKK-like Protein Kinase, Lymphokine-Activated Killer T-Cell-Originated Protein Kinase, Specifically Expressed in the Testis and Activated Lymphoid Cells

Journal of Biological Chemistry

English

Mitotic Kinase PBK/TOPK as a Therapeutic Target for Adult T‑cell Leukemia/Lymphoma

International Journal of Oncology

Cancer Research

Oncology

2018

English

Phosphorylation of IκBα at Serine 32 by T-Lymphokine-Activated Killer Cell-Originated Protein Kinase Is Essential for Chemoresistance Against Doxorubicin in Cervical Cancer Cells

Journal of Biological Chemistry

English

Smaller Protein, Larger Therapeutic Potential: PPM1D as a New Therapeutic Target in Brainstem Glioma

English

Protein Kinase C as a Therapeutic Target

Clinical Cancer Research

Cancer Research

Oncology

2006

English

peIF4E as an Independent Prognostic Factor and a Potential Therapeutic Target in Diffuse Infiltrating Astrocytomas

English

The Roles of Protein Kinase R in Cancer: Potential as a Therapeutic Target

English

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer

Molecular Medicine Reports

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Xuan Lin

T-Lymphokine-Activated Killer Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Glioma

Unique Stabilizing Mechanism Provided by Biocompatible Choline-Based Ionic Liquids for Inhibiting Dissociation of Inactivated Foot-And-Mouth Disease Virus Particles

Related publications

T‐lymphokine‐activated Killer Cell‐originated Protein Kinase (TOPK)‐positive Colorectal Tumor Growth Is Suppressed by Acetylshikonin

Cloning and Expression of a Novel MAPKK-like Protein Kinase, Lymphokine-Activated Killer T-Cell-Originated Protein Kinase, Specifically Expressed in the Testis and Activated Lymphoid Cells

Mitotic Kinase PBK/TOPK as a Therapeutic Target for Adult T‑cell Leukemia/Lymphoma

Phosphorylation of IκBα at Serine 32 by T-Lymphokine-Activated Killer Cell-Originated Protein Kinase Is Essential for Chemoresistance Against Doxorubicin in Cervical Cancer Cells

Smaller Protein, Larger Therapeutic Potential: PPM1D as a New Therapeutic Target in Brainstem Glioma

Protein Kinase C as a Therapeutic Target

peIF4E as an Independent Prognostic Factor and a Potential Therapeutic Target in Diffuse Infiltrating Astrocytomas

The Roles of Protein Kinase R in Cancer: Potential as a Therapeutic Target

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer